Abstract
Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors
Nature Communications Open Access 24 November 2017
-
Health diplomacy: a new approach to the Muslim world?
Globalization and Health Open Access 13 June 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Fingleton, B. Semin. Cell Dev. Biol. 19, 61–68 (2008).
Appels, N.M., Beijnen, J.H. & Schellens, J.H. Oncologist 10, 565–578 (2005).
Neeli, H. & Rader, D.J. Cardiol. Clin. 26, 537–546 (2008).
Boyce, S. & Hill, R.G. in Proceedings of the 9th World Congress on Pain (eds. Devor, M. et al.) 313–324 (International Association for the Study of Pain Press, Vienna, 2000).
Garnier, J.P. Harv. Bus. Rev. 86, 68–70, 72–76, 128 (2008).
Knight, Z.A. & Shokat, K.M. Cell 128, 425–430 (2007).
Newman, R.H. & Zhang, J. Nat. Chem. Biol. 4, 382–386 (2008).
Weigelt, J., McBroom-Cerajewski, L.D., Schapira, M., Zhao, Y. & Arrowmsmith, C.H. Curr. Opin. Chem. Biol. 12, 32–39 (2008).
Edwards, A. Annu. Rev. Biochem. 78, 541–568 (2009).
Kliewer, S.A., Lehmann, J.M. & Willson, T.M. Science 284, 757–760 (1999).
Chawla, A., Repa, J.J., Evans, R.M. & Mangelsdorf, D.J. Science 294, 1866–1870 (2001).
Willson, T.M. & Moore, J.T. Mol. Endocrinol. 16, 1135–1144 (2002).
Tamaoki, T. et al. Biochem. Biophys. Res. Commun. 135, 397–402 (1986).
Hirsch, J.E. Proc. Natl. Acad. Sci. USA 102, 16569–16572 (2005).
Menkes, C.J. et al. J. Rheumatol. 20, 714–717 (1993).
Marshall, K.W., Chiu, B. & Inman, R.D. Arthritis Rheum. 33, 87–90 (1990).
Babenko, V.V. et al. Eur. J. Pain 3, 93–102 (1999).
Jensen, K., Tuxen, C., Pedersen-Bjergaard, U. & Jansen, I. Cephalalgia 11, 175–182 (1991).
Pedersen-Bjergaard, U. et al. Peptides 10, 1147–1152 (1989).
Von Euler, U.S. in Neurotransmitters in Action (ed. Bousfield, D.) 143–150 (Elsevier Biomedical Press, Amsterdam, 1985).
Salt, T.E. & Hill, R.G. Neuroscience 10, 1083–1103 (1983).
Mantyh, P.W. et al. Science 278, 275–279 (1997).
Woolf, C.J. & Mannion, R.J. Lancet 353, 1959–1964 (1999).
Rupniak, N.M.J. & Hill, R.G. in Novel Aspects of Pain Management: Opioids and Beyond (eds. Sawynok, J. & Cowan, A.) 135–155 (Wiley-Liss, New York, 1999).
Gunthorpe, M.J. & Chizh, B. Drug Discov. Today 14, 56–67 (2009).
Gharat, L.A. & Szallasi, A. Expert Opin. Ther. Pat. 18, 159–209 (2008).
Acknowledgements
The authors thank C. Arrowsmith, I. Benjamin, D. Dodds, S. Frye, B. Greenberg, J. Weigelt, H. Widmer, T. Yamada and R. Young for comments on the paper. A.M.E. and C.B. are supported by the Structural Genomics Consortium, which is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary Tables
Supplementary Tables 1–2 (PDF 20 kb)
Rights and permissions
About this article
Cite this article
Edwards, A., Bountra, C., Kerr, D. et al. Open access chemical and clinical probes to support drug discovery. Nat Chem Biol 5, 436–440 (2009). https://doi.org/10.1038/nchembio0709-436
Issue Date:
DOI: https://doi.org/10.1038/nchembio0709-436
This article is cited by
-
Making the collective knowledge of chemistry open and machine actionable
Nature Chemistry (2022)
-
Multicomponent mapping of boron chemotypes furnishes selective enzyme inhibitors
Nature Communications (2017)
-
Raising financing through strategic timing
Nature Nanotechnology (2017)
-
Materials Knowledge Systems in Python—a Data Science Framework for Accelerated Development of Hierarchical Materials
Integrating Materials and Manufacturing Innovation (2017)
-
Comprehensive characterization of the Published Kinase Inhibitor Set
Nature Biotechnology (2016)